VitalConnect

iRhythm Holdings announced a definitive agreement to acquire VitalConnect for approximately $287.5 million ($237.5 million cash + $50 million stock). VitalConnect provides FDA-cleared wearable biosensor and cardiac monitoring technology.

iRhythm Technologies entered a definitive agreement to acquire VitalConnect for total consideration of approximately $287.5 million, consisting of $237.5 million in cash and $50 million in stock, to expand its cardiac monitoring platform.